Jenburkt Pharmaceuticals Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: JENBURPH BSE: 524731

Shareholding pattern / Ownership

Shareholding summary

Jun 2026

Promoter46.62%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings decreased from 46.64% to 46.62% in Jun 2026 qtr

All shareholding details →

Shareholding Trend (Promoter/FII/DII %, real filed periods only)

Promoters holdings decreased from 46.64% to 46.62% in Jun 2026 qtr
DIIs holdings were unchanged at 0.12% in Jun 2026 qtr

Holder	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Latest change
Promoter	46.62%	46.64%	46.65%	46.66%	46.68%	46.69%	46.71%	46.71%	-0.02 pp
FII	—	—	—	—	—	—	—	—	—
DII	0.12%	0.12%	0.12%	0.12%	0.12%	0.12%	—	—	0.00 pp
Mutual funds (within DII)	—	—	—	—	—	—	—	—	—
Public (non-institutional)	—	—	—	—	—	—	—	—	—

Public (non-institutional) = SEBI's Public total minus FII minus DII, shown only where all three were filed. A dash means that holder category filed nothing for that quarter. Holder counts are as filed (entities, not schemes).

Shareholding Pattern (latest quarter)

Category	% holding	Shareholders
Grand Total	100.0000	7103
(B) Public	53.3800	7093
(A) Promoter & Promoter Group	46.6200	10
(C1) Shares underlying DRs	0.0000	0
(C) Non Promoter-Non Public	0.0000	0
(C2) Shares held by Employee Trust	0.0000	0

Named Shareholders